Ewing Sarcoma Clinical Trials in Ann Arbor, Michigan

3 studies are recruiting for ewing sarcoma in Ann Arbor, Michigan right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

  1. Evaluation of Xaluritamig in Adults, Adolescents and Children With Relapsed or Refractory Ewing Sarcoma (EWS)

    The main objectives of this trial are to determine the recommended dose for expansion of xaluritamig (dose confirmation part only) and to determine the safety and tolerability of xaluritamig in adult, adolescent and pediatric participants with relapsed or refractory EWS.

    Stage
    Phase 1
    Ages
    2 and older
    Site
    C.S. Mott Children's Hospital, Ann Arbor, Michigan
    Locations
    13 in total
    Run by
    Amgen

    See if you can join NCT07297979 on ClinicalTrials.gov

  2. Phase 1 Study of INBRX-109 in Subjects With Locally Advanced or Metastatic Solid Tumors Including Sarcomas

    This is a first-in-human, open-label, non-randomized, three-part phase 1 trial of INBRX-109, which is a recombinant humanized tetravalent antibody targeting the human death receptor 5 (DR5).

    Stage
    Phase 1
    Ages
    12 to 85
    Site
    University of Michigan, Ann Arbor, Michigan
    Locations
    37 in total
    Run by
    Inhibrx Biosciences, Inc

    See if you can join NCT03715933 on ClinicalTrials.gov

  3. Lurbinectedin in FET-Fused Tumors

    The purpose of this study is to find out if a drug called lurbinectedin (the "study drug") is safe and effective at treating people with recurrent or relapsed solid tumors, including Ewing sarcoma.

    Stage
    Phase 1
    Ages
    10 and older
    Site
    University of Michigan, Ann Arbor, Michigan
    Locations
    6 in total
    Run by
    Children's Hospital of Philadelphia

    See if you can join NCT05918640 on ClinicalTrials.gov

How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.

What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.

Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.